Biopharmaceutical Company Provides Hope For Dermatitis Treatment

ASLAN Pharmaceuticals: A Beacon of Hope for Atopic Dermatitis Patients.

As an investor it's important to stay updated with major news. Get real-time stock market alerts, news, and research by creating an account here.

In a significant development, ASLAN Pharmaceuticals (ASLN), a clinical-stage biopharmaceutical company, has provided an update on their TREK-DX study and highlighted the potential of Eblasakimab in treating pat…